| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.6M | +1824.9% |
| SG&A Expense | $2.1M | +104.6% |
| Operating Income | -$3.7M | -232.8% |
| Net Income | -$1.5M | +7.8% |
| EPS (Basic) | -$0.13 | +62.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Total Assets | $8.5M | +27.3% |
| Current Liabilities | $2.5M | +2450.2% |
| Total Liabilities | $2.5M | +2450.2% |
| Stockholders' Equity | $5.9M | -9.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.6M | -190.3% |
| Financing Cash Flow | $4.4M | -44.0% |